These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 22413715

  • 21. Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
    Alonso-Coello P, Zhou Q, Guyatt G.
    Thromb Haemost; 2012 Oct; 108(4):647-53. PubMed ID: 22918481
    [Abstract] [Full Text] [Related]

  • 22. Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
    Yates SW.
    Hosp Pract (1995); 2011 Oct; 39(4):7-16. PubMed ID: 22056819
    [Abstract] [Full Text] [Related]

  • 23. [Dabigatran, a new oral anticoagulant].
    Uchiyama S.
    Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
    [Abstract] [Full Text] [Related]

  • 24. [The results of the RE-lY study promise more effective, safer and easier prevention of embolic complications in patients with non-valvular atrial fibrillation].
    Vojácek J.
    Vnitr Lek; 2009 Nov; 55(11):1085-8. PubMed ID: 20017441
    [Abstract] [Full Text] [Related]

  • 25. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
    [Abstract] [Full Text] [Related]

  • 26. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 Jun; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

  • 27. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 28. Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
    Hughes PJ, Freeman MK.
    Consult Pharm; 2012 Jun; 27(6):445-52. PubMed ID: 22698551
    [Abstract] [Full Text] [Related]

  • 29. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 30. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
    Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ, RE-LY Investigators.
    Ann Intern Med; 2011 Nov 15; 155(10):660-7, W204. PubMed ID: 22084332
    [Abstract] [Full Text] [Related]

  • 33. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
    Szapary L, Fehér G, Bosnyák E, Deli G, Csécsei P.
    Ideggyogy Sz; 2013 May 30; 66(5-6):165-74. PubMed ID: 23909016
    [Abstract] [Full Text] [Related]

  • 34. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L, Sherman O.
    Ann Pharmacother; 2011 Jul 30; 45(7-8):e40. PubMed ID: 21712509
    [Abstract] [Full Text] [Related]

  • 35. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK, Kouides PA.
    Ann Pharmacother; 2012 Apr 30; 46(4):e10. PubMed ID: 22496474
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 38. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
    Paikin JS, Haroun MJ, Eikelboom JW.
    Expert Rev Cardiovasc Ther; 2011 Mar 03; 9(3):279-86. PubMed ID: 21438804
    [Abstract] [Full Text] [Related]

  • 39. Dabigatran versus warfarin in patients with mechanical heart valves.
    Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F, RE-ALIGN Investigators.
    N Engl J Med; 2013 Sep 26; 369(13):1206-14. PubMed ID: 23991661
    [Abstract] [Full Text] [Related]

  • 40. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.
    J Stroke Cerebrovasc Dis; 2012 Apr 26; 21(3):165-73. PubMed ID: 22440950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.